Helius Other Liab from 2010 to 2024

HSDT Stock  USD 0.49  0.03  6.52%   
Helius Medical Other Liabilities yearly trend continues to be comparatively stable with very little volatility. Other Liabilities is likely to outpace its year average in 2024. From the period from 2010 to 2024, Helius Medical Other Liabilities quarterly data regression had r-value of  0.55 and coefficient of variation of  128.69. View All Fundamentals
 
Other Liabilities  
First Reported
2010-12-31
Previous Quarter
8.2 M
Current Value
8.6 M
Quarterly Volatility
M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Helius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Helius Medical's main balance sheet or income statement drivers, such as Interest Expense of 244.2 K, Selling General Administrative of 9.6 M or Other Operating Expenses of 16.1 M, as well as many indicators such as Price To Sales Ratio of 7.21, Dividend Yield of 0.0 or PTB Ratio of 2.18. Helius financial statements analysis is a perfect complement when working with Helius Medical Valuation or Volatility modules.
  
Check out the analysis of Helius Medical Correlation against competitors.

Latest Helius Medical's Other Liab Growth Pattern

Below is the plot of the Other Liab of Helius Medical Technologies over the last few years. It is Helius Medical's Other Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Helius Medical's overall financial position and show how it may be relating to other accounts over time.
Other Liab10 Years Trend
Slightly volatile
   Other Liab   
       Timeline  

Helius Other Liab Regression Statistics

Arithmetic Mean2,322,359
Geometric Mean1,017,222
Coefficient Of Variation128.69
Mean Deviation2,245,908
Median1,581,000
Standard Deviation2,988,680
Sample Variance8.9T
Range8.4M
R-Value0.55
Mean Square Error6.7T
R-Squared0.30
Significance0.03
Slope368,875
Total Sum of Squares125.1T

Helius Other Liab History

20248.6 M
20238.2 M
20227.1 M
2021193 K
2020220 K
2016245 K
20151.7 M

About Helius Medical Financial Statements

Helius Medical shareholders use historical fundamental indicators, such as Other Liab, to determine how well the company is positioned to perform in the future. Although Helius Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Helius Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Helius Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Other Liabilities8.2 M8.6 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Helius Stock Analysis

When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.